ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

N018F In force

ZIPRASIDONUM
◀ Back 📄 CNAS document
The protocol name and text are reproduced in Romanian, exactly as published by CNAS.
Sublist / disease code
C1-G15
reimbursement list
Continuation by the family doctor
YES
Listed since
November 2025
position 241 in the order
Last amended
November 2025
1 versions since November 2025
1

Medicines

From the protocol title (medicines of the protocol) and other substances mentioned in the text (combinations, previous treatments, interactions)

Medicines of the protocol

2

Brand products authorised in Romania

From the ANMDM register, for the medicines of the protocol

ZIPRASIDONUM 4 products
List of products (4 presentations)
INNBrand nameFormStrengthHolderATCRx
ZIPRASIDONUMZYPSILA 20 mgCAPS.20mgKRKA, D.D., NOVO MESTO - SLOVENIAN05AE04PRF
ZIPRASIDONUMZYPSILA 40 mgCAPS.40mgKRKA, D.D., NOVO MESTO - SLOVENIAN05AE04PRF
ZIPRASIDONUMZYPSILA 60 mgCAPS.60mgKRKA, D.D., NOVO MESTO - SLOVENIAN05AE04PRF
ZIPRASIDONUMZYPSILA 80 mgCAPS.80mgKRKA, D.D., NOVO MESTO - SLOVENIAN05AE04PRF
3

History

The versions of the protocol from the Ministry of Health / CNAS orders, with medicines added / removed and the changed text

Protocol text (version of November 2025, in Romanian)
Protocol terapeutic corespunzător poziţiei nr. 241, cod (N018F): DCI ZIPRASIDONUM Forme farmaceutice: orale şi parenterale I. Indicaţii: Schizofrenie, alte psihoze, episod maniacal, la pacienţii cu vârsta peste 18 ani II. Doze: 40 - 160 mg/zi III. Criterii de includere: Diagnostic ICD 10 IV. Monitorizare: Toleranţă, eficacitate, EKG V. Evaluare: 1 - 2 luni VI. Prescriptori: Iniţiere: medic în specialitatea psihiatrie Continuare: medic în specialitatea psihiatrie sau medic de familie, care poate continua prescrierea pentru o perioadă de 3 - 6 luni, pe baza scrisorii medicale transmise de medicul în specialitatea psihiatrie.

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.